Premium
Valganciclovir Versus IV Ganciclovir for Therapy of Cytomegalovirus Viremia: Has Victory Been Achieved?
Author(s) -
Avery R. K
Publication year - 2007
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2007.01925.x
Subject(s) - valganciclovir , medicine , ganciclovir , viremia , cytomegalovirus , virology , victory , human cytomegalovirus , herpesviridae , viral disease , virus , politics , political science , law
The VICTOR trial is an important step in showing that oral valganciclovir is effective in the treatment of CMV disease, but many questions remain before we can declare victory over CMV disease. See also article by Åsberg et al in this issue on page 2106.